Loading
II
Ignyta, Inc. Stock: price and insider trades · United States
Ignyta, Inc.: what insiders have been doing
Only a handful of insider records exist for Ignyta, Inc., the last one from 11 January 2016, too few to describe a trend. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 11 January 2016
Declarations8 total
6,960 sharesCommon StockSEC:0001209191-16-090822:0
26,400 sharesCommon StockSEC:0001209191-16-090810:0
28,800 sharesCommon StockSEC:0001209191-16-090807:0
72,000 sharesCommon StockSEC:0001209191-16-090805:0
26,400 sharesCommon StockSEC:0001209191-16-090812:0
12,000 sharesCommon StockSEC:0001209191-16-090815:0
26,400 sharesCommon StockSEC:0001209191-16-090817:0
7,920 sharesCommon StockSEC:0001209191-16-090820:0
8 of 8 declarations
About Ignyta, Inc.
Ignyta, Inc. is a biopharmaceutical company focused on developing targeted therapies for cancer. It is listed on NASDAQ under the ticker RXDX.
